Chardan Details?
Just curious to learn more about Chardan. Don't know much about them, but they seem like a sizeable bank.
Do they take SA's, how is comp, exit opps, rep?
Thank you!
Just curious to learn more about Chardan. Don't know much about them, but they seem like a sizeable bank.
Do they take SA's, how is comp, exit opps, rep?
Thank you!
| +216 | Coverage Banking is Paradise | 25 | 1h |
| +75 | My Motivation Is At An All Time High | 13 | 1d |
| +74 | London Recruiting is Paradise | 32 | 34m |
| +62 | Lost all ambition / don’t care at all anymore | 28 | 16h |
| +52 | Are Canadians still get jobs in the US? | 38 | 13m |
| +31 | Is 7 years in banking enough to retire, or am I delusional? | 23 | 7h |
| +29 | MM IB --> NYC IB? | 14 | 1d |
| +24 | Negotiating VP Sign-On Bonus (NOT Tied to Deferred Comp)? | 21 | 2h |
| +24 | Should I escape the matrix | 3 | 1d |
| +23 | Lawyer moving into Banking | 18 | 1d |
Career Resources
Bump
bump
Chardan is a SPAC powerhouse that has had an absolutely killer past several years.
With a lot of SPACs not successfully de-SPACing anymore and returning capital to investors, the sponsors got burned because they have paid a bunch of fees to a banker like Chardan, EarlyBird, or a BB bank’s ECM team. This is what kills the deal flow.
SPACs are the red-headed stepchild of Wall Street right now, but if you love the product, there will always be more SPACs.
Feel free to ask any follow-ons about the product.
Do you have any info on their equity research team? Seems like this is still connected to their SPAC practice but not exactly sure how.
Is it just SPAC sponsors paying for coverage?
They don’t cover a ton of stocks. Most of the stocks are biotech, which makes sense given that it was a popular de-SPAC target market. Most of the biotech stocks were actually never SPACs; I think it’s just a core competency they had and felt they understood.
Then there’s the other tech coverage, and that list reads like a who’s who of SPACs. BMTX, PLBY, KITT, PRST, PET, etc. Giving coverage of the stock after the fact supports the IPO activity of the firm and is good karma.
I think they have a small, but non-SPAC biotech arm which evolved from their de-SPAC activities, and they cover some of their own cooking on the SPAC side as goodwill.
Very helpful, do you have any color on culture, WLB, bonus figures, etc.
Reiciendis id molestiae eveniet et voluptatibus nulla. Atque consectetur delectus aut.
Ducimus voluptas quaerat tenetur et. Omnis ut velit veniam voluptatem voluptatem neque. Amet placeat corporis aspernatur ipsam aperiam repellat. Sit vel voluptatem mollitia quia amet eaque quidem. Et recusandae consequatur nulla placeat dolorum iure fugit. Et nam debitis recusandae ut.
Similique eos accusamus numquam natus incidunt quibusdam voluptas. Eos blanditiis voluptatem veritatis saepe iste. Sunt nihil corrupti vel fuga sapiente.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...